Akzo Nobel N.V. (AKZOY)
OTC: AKZOY
· Real-Time Price · USD
21.82
0.00 (0.00%)
At close: Aug 14, 2025, 3:57 PM
22.14
1.47%
Pre-market: Aug 15, 2025, 08:28 AM EDT
Akzo Nobel Income Statement
Financials in EUR. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2.63B | 2.61B | 2.62B | 2.67B | 2.78B | 2.64B | 2.53B | 2.74B | 2.74B | 2.66B | 2.61B | 2.86B | 2.85B | 2.52B | 2.4B | 2.41B | 2.51B | 2.26B |
Cost of Revenue | 1.59B | 1.56B | 1.59B | 1.58B | 1.64B | 1.55B | 1.5B | 1.62B | 1.64B | 1.68B | 1.68B | 1.88B | 1.82B | 1.54B | 1.49B | 1.48B | 1.48B | 1.28B |
Gross Profit | 1.04B | 1.05B | 1.03B | 1.08B | 1.14B | 1.09B | 1.02B | 1.12B | 1.11B | 982M | 931M | 978M | 1.03B | 981M | 909M | 927M | 1.03B | 985M |
Operating Income | 214M | 192M | 127M | 264M | 269M | 261M | 193M | 354M | 279M | 182M | 103M | 168M | 205M | 232M | 205M | 226M | 384M | 303M |
Interest Income | 18M | n/a | n/a | 12M | 16M | n/a | 25M | 18M | 15M | 19M | 10.2M | 4M | 1M | 15M | n/a | n/a | 13M | 11M |
Pretax Income | 179M | 169M | 95M | 247M | 239M | 252M | 93M | 294M | 239M | 151M | 51M | 141M | 182M | 228M | 202M | 213M | 388M | 302M |
Net Income | 124M | 107M | 21M | 163M | 177M | 181M | 41M | 189M | 118M | 94M | 17M | 84M | 106M | 154M | 187M | 164M | 261M | 217M |
Selling & General & Admin | 826M | 855M | 898M | 819M | 872M | 825M | 831M | 815M | 823M | 796M | -855M | 811M | 826M | 749M | -796M | 701M | 708M | 683M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | 270M | n/a | n/a | n/a | 258M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | -2M | 1M | 1M | n/a | 6M | n/a | n/a | n/a | n/a | 4M | 1.68B | -1M | 2M | n/a | 1.5B | n/a | -58M | -1M |
Operating Expenses | 824M | 856M | 899M | 819M | 872M | 826M | 831M | 768M | 827M | 800M | 828M | 810M | 828M | 749M | 704M | 701M | 650M | 682M |
Interest Expense | 68M | 30M | 36M | 44M | 47M | 16M | 42M | 68M | 45M | 57M | 35.7M | 33M | 29M | 27M | 43M | 19M | 4M | 19M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 2.94B | n/a | n/a | n/a | 2.31B | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.41B | 2.42B | 2.49B | 2.4B | 2.52B | 2.38B | 2.34B | 2.39B | 2.46B | 2.48B | 2.5B | 2.69B | 2.65B | 2.29B | 2.2B | 2.18B | 2.13B | 1.96B |
Income Tax Expense | 44M | 48M | 59M | 77M | 53M | 57M | 49M | 96M | 106M | 45M | 34M | 51M | 67M | 62M | 2M | 48M | 123M | 73M |
Shares Outstanding (Basic) | 1.54B | 1.54B | 1.54B | 1.54B | 1.54B | 1.54B | 1.54B | 1.54B | 1.54B | 1.53B | 1.54B | 1.57B | 1.58B | 1.6B | 1.6B | 1.66B | 1.68B | 1.7B |
Shares Outstanding (Diluted) | 1.55B | 1.54B | 1.54B | 1.54B | 1.55B | 1.54B | 1.54B | 1.55B | 1.54B | 1.53B | 1.54B | 1.57B | 1.58B | 1.6B | 1.6B | 1.66B | 1.69B | 1.7B |
EPS (Basic) | 0.08 | 0.07 | 0.01 | 0.11 | 0.12 | 0.12 | 0.03 | 0.12 | 0.08 | 0.06 | 0.01 | 0.05 | 0.07 | 0.10 | 0.13 | 0.10 | 0.16 | 0.13 |
EPS (Diluted) | 0.08 | 0.07 | 0.01 | 0.11 | 0.11 | 0.12 | 0.03 | 0.12 | 0.08 | 0.06 | 0.01 | 0.05 | 0.07 | 0.10 | 0.13 | 0.10 | 0.15 | 0.13 |
EBITDA | 339M | 293M | 225M | 388M | 369M | 357M | 315M | 451M | 376M | 277M | 202M | 271M | 292M | 326M | 299M | 317M | 482M | 398M |
EBIT | 247M | 199M | 131M | 292M | 291M | 268M | 142M | 345M | 310M | 189M | 84M | 174M | 205M | 255M | 245M | 232M | 398M | 314M |
Depreciation & Amortization | 92M | 94M | 94M | 96M | 92M | 89M | 93M | 89M | 88M | 87M | 95M | 97M | 87M | 89M | 94M | 87M | 84M | 84M |